Insider · CIK 0002099111
Yaron Shaer
Files at KLAR (Klarna Group plc). First filing -, latest -.
In brief
Yaron Shaer files SEC Form 4 as officer at KLAR (Klarna Group plc). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yaron Shaer has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | KLAR Klarna Group plc | MOption exercise Klarna Group plc Ordinary Shares | +48 | - | - | 22,452 | Jul 1, 2026 |
| Jun 30, 2026 | KLAR Klarna Group plc | AGrant or award Klarna Group plc Ordinary Shares | +13,655 | - | - | 36,107 | Jul 1, 2026 |
| Apr 2, 2026 | KLAR Klarna Group plc | AGrant or award Klarna Group plc Ordinary Shares | +21,289 | - | - | 22,312 | Apr 16, 2026 |
| Apr 13, 2026 | KLAR Klarna Group plc | MOption exercise Klarna Group plc Ordinary Shares | +92 | - | - | 22,404 | Apr 16, 2026 |
Questions about Yaron Shaer
Answered from the filings on this page, as of the latest one.
Is Yaron Shaer buying or selling?
Yaron Shaer has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yaron Shaer's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yaron Shaer has 0.
Where does Yaron Shaer file Form 4?
Yaron Shaer has filed Form 4 at KLAR (Klarna Group plc) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.